POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
High Impact

Missouri prohibits health plans from denying or charging more for nonopioid pain drugs over opioids

Original title: Enacts provisions relating to insurance coverage of alternatives to opioid drugs

Last action · February 24, 2026: Voted Do Pass S Insurance and Banking CommitteeSponsor: Mike Henderson

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

Health benefit plans in Missouri are prohibited from denying coverage for prescribed nonopioid prescription drugs in favor of opioids, requiring patients to try opioids first, or charging higher copays for nonopioids starting January 1, 2027.

Why it matters

Patients prescribed nonopioid alternatives for acute pain will have equal cost and access protections compared to opioid medications under covered health plans.

Background
  • Senate Bill 902 was introduced during the Second Regular Session of the 103rd General Assembly of Missouri. context

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

enrollee

Enrollees prescribed nonopioid drugs for acute pain gain guaranteed coverage parity and protection against mandatory opioid step therapy or higher copays.

Directly affected

health benefit plan

Health benefit plans must alter their drug formularies and coverage policies to eliminate higher cost-sharing, step therapy, and coverage denials for nonopioid alternatives.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Can my health plan force me to try an opioid before approving a nonopioid pain medication?
No. Health benefit plans are prohibited from requiring an enrollee to try an opioid prescription drug before providing coverage of a nonopioid prescription drug.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

5 actions
  1. Feb 24, 2026SenateCommittee
    Voted Do Pass S Insurance and Banking Committee
  2. Feb 10, 2026Senate
    Hearing Conducted S Insurance and Banking Committee
  3. Jan 8, 2026SenateFloor
    Second Read and Referred S Insurance and Banking Committee
  4. Jan 7, 2026SenateIntroduced
    S First Read
  5. Dec 1, 2025Senate
    Prefiled

Version history

Only one version on file - nothing to compare yet. The text on record is the 4240S.01I - Introduced version. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

cross reference95% confidence

Identical Legislation

The official summary notes that SB 902 is identical to HB 1680 and HB 1966 from the same legislative session.

Connected Entities

Mike Henderson, Kristina Martin
PersonMike Henderson“Senator, District 3, introducing Senate Bill 902”Map →
PersonKristina Martin“Secretary of the Senate”Map →

Sources

Open source document

www.senate.mo.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz40
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record